A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification-Reference-Cited by-同舟云学术

A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification

Published:2013-06 Issue:2 Volume:57 Page:141-146
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Lee Peter,Plavina Tatiana,Castro Albert,Berman Melissa,Jaiswal Dipeshkumar,Rivas Suzanne,Schlain Brian,Subramanyam Meena

Funder

Biogen Idec Inc.

Elan Pharmaceuticals, Inc.

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference9 articles.

1. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies;Major;Annu Rev Med,2010

2. Progressive multifocal leukoencephalopathy and newer biological agents;Berger;Drug Saf,2010

3. Anti-JC virus antibodies: implications for PML risk stratification;Gorelik;Ann Neurol,2010

4. Multi-site analytical validation of an assay to detect anti-JCV antibodies in human serum and plasma;Plavina;J Clin Virol,2012

5. Risk of natalizumab-associated progressive multifocal leukoencephalopathy;Bloomgren;N Engl J Med,2012

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroaxonal damage in natalizumab-treated MS patients: The role of JCV antibody titres;Multiple Sclerosis Journal;2024-06-14

2. Association of B-cell activating factor gene variants with serum anti-JCV antibody positivity in male patients with multiple sclerosis under natalizumab treatment: Implications for progressive multifocal leukoencephalopathy risk stratification;Journal of the Neurological Sciences;2024-06

3. The impact of social distancing measures on anti–JC virus serostatus changes before and during the COVID-19 pandemic in US patients with multiple sclerosis;Multiple Sclerosis Journal;2024-02-26

4. Generation of JC Polyoma Pseudovirus for High-Throughput Measurement of Neutralizing Antibodies;Diagnostics;2024-01-31

5. Practical Clinical Guidelines for Natalizumab Treatment in Patients With Relapsing Multiple Sclerosis;Journal of Infusion Nursing;2023-11